Source comparison
CJC-1295 vs Ipamorelin: Side-by-Side Comparison
Type GHRH analog GHRP (ghrelin mimetic) Receptor Target GHRH receptor GHS-R1a receptor Half-Life 6–8 days ~2 hours Injection Frequency 1–2 times/week Daily or twice daily GH Release Pattern Sustained, long plateau Rapid, short peak Impact on Other Hormones Min
This comparison does not assign a generated winner or score.
- Type
- GHRH analog
- GHRP (ghrelin mimetic)
- Receptor Target
- GHRH receptor
- GHS-R1a receptor
- Half-Life
- 6–8 days
- ~2 hours
- Injection Frequency
- 1–2 times/week
- Daily or twice daily
- GH Release Pattern
- Sustained, long plateau
- Rapid, short peak
- Impact on Other Hormones
- Minimal
- Common Side Effects
- Injection-site reaction, water retention
- Headache, hunger, flushing
- Best Use Case
- Steady GH support
- Pulsatile GH bursts